Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO, EVP and Treasurer William J. Peters filed a Form 4 on November 18, 2026, disclosing an option exercise and sale of 11,000 shares of common stock on November 16, 2026, pursuant to a Rule 10b5-1 trading plan.
Key Highlights
- Option exercise: Peters exercised an employee stock option to acquire 11,000 shares of common stock at an exercise price of $17.99 per share on November 16, 2026.
- Shares sold: 11,000 shares of common stock were disposed of at $29.99 per share on November 16, 2026.
- 10b5-1 plan: According to the filing, the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Peters on March 10, 2026.
- Remaining direct holdings: Following the transactions, Peters directly holds 167,076 shares of common stock.
- Remaining options: Peters retains 56,833 shares underlying employee stock options with an exercise price of $17.99 and an expiration date of March 17, 2031, which the filing states are fully vested and immediately exercisable.
Peters Option Exercise and Sale Details for Amphastar Pharmaceuticals
According to the Form 4 filed with the U.S. Securities and Exchange Commission, William J. Peters, CFO, EVP and Treasurer of Amphastar Pharmaceuticals, Inc., reported two transactions in the company's common stock on November 16, 2026. Peters exercised an employee stock option covering 11,000 shares at an exercise price of $17.99 per share, with the filing noting that "shares subject to the option are fully vested and immediately exercisable." Following the exercise, Peters' direct beneficial ownership temporarily stood at 178,076 shares.
In the same session, Peters disposed of 11,000 shares at $29.99 per share, reducing his direct beneficial ownership to 167,076 shares of common stock. The filing identifies the sale as a transaction code "S" under a Rule 10b5-1 trading plan that Peters adopted on March 10, 2026. The filing box indicating a transaction "made pursuant to a contract, instruction or written plan" satisfying Rule 10b5-1(c) conditions is checked.
In Table II of the filing, Peters' remaining derivative securities position consists of 56,833 shares underlying employee stock options at a $17.99 exercise price, expiring March 17, 2031, all held directly. The filing was signed by William J. Peters and dated November 18, 2026.
What Was Disclosed
Amphastar Pharmaceuticals CFO William J. Peters disclosed an option exercise and same-day sale of 11,000 shares on November 16, 2026, carried out under a pre-established 10b5-1 plan, leaving him with 167,076 shares and 56,833 vested option shares outstanding.





Please wait processing your request...